Clinical Trial Update: Single Ascending Dose Study of TRN-157 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 single ascending dose study of TRN-157 in healthy subjects has completed; the study evaluated safety, tolerability, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TRN-157

Snippet

Sponsor: Theron Pharmaceuticals, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED